Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants

NCT00390910 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL: Pneumococcal conjugate vaccine GSK1024850A
BIOLOGICAL: Infanrix hexa

Sponsor

GlaxoSmithKline